A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike

SARS-CoV-2 has emerged as a global pathogen1,2, sparking urgent vaccine development efforts with the trimeric spike3,4. However, the inability of antibodies like CR30225, which binds a cryptic spike epitope with nanomolar affinity6, to neutralize virus, suggests a spike-based means of neutralization escape. Here, we show the SARS-CoV-2 spike to have 10% the unfolding enthalpy of a globular protein at physiological pH, where it is recognized by antibodies like CR3022, and up to 10-times more unfolding enthalpy at endosomal pH, where it sheds such antibodies, suggesting that the spike evades potentially neutralizing antibody through a pH-dependent mechanism of conformational masking. To understand the compatibility of this mechanism with ACE2-receptor interactions, we carried out binding measurements and determined cryo-EM structures of the spike recognizing up to three ACE2 molecules at both physiological and endosomal pH. In the absence of ACE2, cryo-EM analyses indicated lower pH to reduce conformational heterogeneity. Single-receptor binding domain (RBD)-up conformations dominated at pH 5.5, resolving into a locked all-down conformation at lower pH through lowering of RBD and refolding of a pH-dependent switch. Notably, the emerging Asp614Gly strain7 partially destabilizes the switch that locks RBD down, thereby enhancing functional interactions with ACE2 while reducing evasion by conformational masking.

[1]  M. Baker,et al.  Outcome of the First Electron Microscopy Validation Task Force Meeting , 2012, Structure.

[2]  K. Shi,et al.  Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.

[3]  J. Skehel,et al.  SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects , 2020, Nature Structural & Molecular Biology.

[4]  David N Mastronarde,et al.  Automated electron microscope tomography using robust prediction of specimen movements. , 2005, Journal of structural biology.

[5]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[6]  Frank DiMaio,et al.  Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy , 2016, Nature Structural &Molecular Biology.

[7]  Anchi Cheng,et al.  Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.

[8]  Linqi Zhang,et al.  Human neutralizing antibodies elicited by SARS-CoV-2 infection , 2020, Nature.

[9]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[10]  Haixia Zhou,et al.  Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding , 2016, Cell Research.

[11]  Andrew D. Robertson,et al.  Protein Structure and the Energetics of Protein Stability. , 1997, Chemical reviews.

[12]  Ilya J. Finkelstein,et al.  Structure-based design of prefusion-stabilized SARS-CoV-2 spikes , 2020, Science.

[13]  Barney S. Graham,et al.  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.

[14]  G. Simmons,et al.  Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and Infectivity , 2007, Journal of Virology.

[15]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[16]  B. Haynes,et al.  Cold sensitivity of the SARS-CoV-2 spike ectodomain , 2020, bioRxiv.

[17]  Pardis C Sabeti,et al.  SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain , 2020, bioRxiv.

[18]  B Honig,et al.  On the pH dependence of protein stability. , 1993, Journal of molecular biology.

[19]  V. Turk,et al.  Lysosomes as “Suicide Bags” in Cell Death: Myth or Reality?* , 2009, The Journal of Biological Chemistry.

[20]  Shaun Rawson,et al.  Distinct conformational states of SARS-CoV-2 spike protein , 2020, Science.

[21]  Xiaoxu Tian,et al.  Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics , 2020, Glycobiology.

[22]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[23]  H. Deng,et al.  The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera , 2020 .

[24]  M. Diamond,et al.  A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection , 2019, Nature Immunology.

[25]  Yi Shi,et al.  Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains , 2017, Nature Communications.

[26]  David J. Fleet,et al.  cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.

[27]  A. Rodríguez-Morales,et al.  Testing Dilemmas: Post negative, positive SARS-CoV-2 RT-PCR – is it a reinfection? , 2020, Travel Medicine and Infectious Disease.

[28]  R. Welsh,et al.  Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail , 2020, Science.

[29]  David I Stuart,et al.  Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike , 2020, bioRxiv.

[30]  D. Veesler,et al.  Structural and functional analysis of a potent sarbecovirus neutralizing antibody , 2020 .

[31]  Conrad C. Huang,et al.  UCSF ChimeraX: Meeting modern challenges in visualization and analysis , 2018, Protein science : a publication of the Protein Society.

[32]  Young Do Kwon,et al.  Crystal structure , conformational fixation , and entry-related interactions of mature ligand-free HIV-1 Env , 2016 .

[33]  John A.G. Briggs,et al.  A thermostable, closed SARS-CoV-2 spike protein trimer , 2020, Nature Structural & Molecular Biology.

[34]  Thomas C Terwilliger,et al.  New tools for the analysis and validation of cryo-EM maps and atomic models , 2018, bioRxiv.

[35]  D. Ho,et al.  Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. , 2020, SSRN.

[36]  Hemant D. Tagare,et al.  The Local Resolution of Cryo-EM Density Maps , 2013, Nature Methods.

[37]  D. Burton,et al.  Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model , 2020, Science.

[38]  L. Stamatatos,et al.  Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual , 2020, bioRxiv.

[39]  Xinquan Wang,et al.  Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 , 2018, PLoS pathogens.

[40]  Bonnie Berger,et al.  Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs , 2019, Nature Methods.

[41]  Pardis C Sabeti,et al.  Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant , 2020, bioRxiv.

[42]  Amalio Telenti,et al.  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody , 2020, Nature.

[43]  J. Sodroski,et al.  Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike , 2020, Nature.

[44]  Cinque S. Soto,et al.  Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine , 2016, Nature Structural &Molecular Biology.

[45]  A. Walls,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[46]  M. Beltramello,et al.  Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4 , 2018, Proceedings of the National Academy of Sciences.

[47]  M. Borgnia,et al.  Controlling the SARS-CoV-2 Spike Glycoprotein Conformation , 2020, bioRxiv.

[48]  Jan H. Jensen,et al.  PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.

[49]  Linqi Zhang,et al.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.

[50]  Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability , 2020, Science.

[51]  Z. Tong,et al.  Retest positive for SARS‐CoV‐2 RNA of “recovered” patients with COVID‐19: Persistence, sampling issues, or re‐infection? , 2020, Journal of medical virology.

[52]  P. Gautret,et al.  Recurrence of positive SARS‐CoV‐2 in patients recovered from COVID‐19 , 2020, Journal of medical virology.

[53]  D. Montefiori,et al.  Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 , 2020, bioRxiv.

[54]  H. Schuitemaker,et al.  A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism , 2015, Nature Communications.

[55]  Sjors H.W. Scheres,et al.  RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.

[56]  A. Walls,et al.  Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.

[57]  L. Guddat,et al.  Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase , 2020, Cell.

[58]  R. Baric,et al.  Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry , 2020, PLoS pathogens.

[59]  Yan Liu,et al.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.

[60]  John P. Moore,et al.  Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes , 2015, Cell.

[61]  Thomas C Terwilliger,et al.  Automated map sharpening by maximization of detail and connectivity , 2018, bioRxiv.

[62]  J. Sodroski,et al.  Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike , 2020, bioRxiv.

[63]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[64]  M. Farzan,et al.  The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity , 2020, bioRxiv.

[65]  N. Grigorieff,et al.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.

[66]  A Leith,et al.  SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. , 1996, Journal of structural biology.

[67]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[68]  Wen Jiang,et al.  EMAN2: an extensible image processing suite for electron microscopy. , 2007, Journal of structural biology.

[69]  I. Wilson,et al.  A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV , 2020, Science.

[70]  David Cyranoski,et al.  The coronavirus pandemic in five powerful charts , 2020, Nature.

[71]  Daniel Wrapp,et al.  Site-specific glycan analysis of the SARS-CoV-2 spike , 2020, Science.

[72]  William J. Liu,et al.  A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 , 2020, Nature.

[73]  S. Kishigami,et al.  Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry , 2020, bioRxiv.

[74]  Yang Yang,et al.  A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 , 2020, Science.

[75]  Fang Li,et al.  Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins , 2018, PLoS pathogens.

[76]  Jaap Goudsmit,et al.  Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants , 2006, PLoS medicine.

[77]  J. McLellan,et al.  Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers , 2020, Cell Reports.

[78]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[79]  Chao Zhang,et al.  Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM , 2020, Science Advances.

[80]  J. Nie,et al.  Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 , 2020, Emerging microbes & infections.

[81]  Anton Andonov,et al.  Architecture of the SARS coronavirus prefusion spike , 2006, Nature Structural &Molecular Biology.

[82]  Tongqing Zhou,et al.  Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site , 2009, PLoS pathogens.

[83]  X. Xie,et al.  Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells , 2020, Cell.

[84]  Bonnie Berger,et al.  Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs , 2018, Nature Methods.

[85]  Nicholas C. Wu,et al.  A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV , 2020, Science.

[86]  M. Nussenzweig,et al.  Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies , 2020, Cell.

[87]  M. Whitt Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. , 2010, Journal of Virological Methods.

[88]  John A.G. Briggs,et al.  Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions , 2020, bioRxiv.

[89]  C. Rice,et al.  Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.

[90]  Peter D. Kwong,et al.  HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.

[91]  Neville E. Sanjana,et al.  The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types , 2020 .

[92]  Honghao Sun,et al.  Evaluating nanoparticle sensor design for intracellular pH measurements. , 2011, ACS nano.

[93]  Mario Roederer,et al.  Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing , 2011, Science.

[94]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[95]  D. Ho,et al.  Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes , 2020, bioRxiv.

[96]  Barney S. Graham,et al.  Pre-fusion structure of a human coronavirus spike protein , 2016, Nature.

[97]  David C. Richardson,et al.  MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes , 2004, Nucleic Acids Res..

[98]  Jan H. Jensen,et al.  Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. , 2011, Journal of chemical theory and computation.